SES
23.2.2021 08:52:12 CET | Business Wire | Press release
Four of the top five major cruise companies have entered into long-term strategic framework agreements, with the majority extending through 2026 and beyond, for services delivered over SES's next-generation O3b mPOWER communications system, SES announced today. These agreements will enable enhanced connectivity experiences onboard their current fleets as well as ships planned as part of their extensive new-build programmes, and result in a backlog of over EUR 220 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222006011/en/
The advanced connectivity solutions delivered by SES will elevate guest connectivity to provide an ultimate digital immersive experience, enabling more wearable technologies and unlocking more personalised services. This reflects a major trend across the cruise industry and the priorities of leading cruise companies as they prepare to resume sailing. The latest contracts with SES Networks reinforce that SES is the clear market leader within the cruise connectivity segment, having secured significant market share of the cruise companies' mega new-build ship programmes. Dating back to 2019, SES has provided over 13 Gbps – or 2/3 of the total capacity delivered to the cruise industry.
O3b mPOWER is SES's global terabit-level scalable constellation that will operate in medium earth orbit (MEO) – or 8,000km away from earth. Based on the proven success of SES's current O3b system, the new system provides an unprecedented increase in flexibility and throughput and is capable of continuously delivering multiple gigabits per second to a single ship anywhere on earth during seasonal peaks and in areas of high density. O3b mPOWER’s advanced technical features, which include a “follow-the-ship” capability, allow for maximum efficiency in delivering the highest throughput available today wherever a ship is travelling. The new O3b mPOWER system provides the ideal combination of global coverage and low-latency, high-throughput performance for the cruise market, ensuring seamless immersive wi-fi and connectivity experiences.
With satellites scheduled to launch in late 2021 and service beginning in 2022, the high-performance connectivity delivered by O3b mPOWER will help the cruise industry to:
- Leverage a highly-resilient global network to deliver an always-on fibre-like connectivity experience
- Deliver seamless and secured access to cloud-based platforms and applications for shipboard productivity, passenger communications and entertainment
- Dynamically optimise the required bandwidth and increased connectivity to any ship wherever and whenever it may be
- Deliver fastest internet speeds at sea, resulting in truly immersive guest experiences
- Achieve cruise liners’ operational efficiencies by enabling real-time condition monitoring and other connected Operational Technology (OT)
“COVID-19 has been challenging for the cruise industry. At the same time, it has also enabled major players in the industry to re-strategise on their plans for the future and focus on technology-driven innovation and how they can outdo themselves in creating the best holiday experience for passengers, and high-performance connectivity is central to those strategies. We are pleased to be co-creating these advanced solutions along with our customers and ensuring we can meet their future needs,” said JP Hemingway, CEO of SES Networks.
Follow us on:
https://twitter.com/SES_Satellites
https://www.facebook.com/SES.Satellites
https://www.youtube.com/ses
https://www.linkedin.com/company/ses/
https://www.instagram.com/ses_satellites/
Read our Blogs >
Visit the Media Gallery >
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,200 channels and has an unparalleled reach of 367 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222006011/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom